Insider holders · CIK 0001173281
Ohr Pharmaceutical Inc · OHRP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Jason Scott SlakterChief Executive Officer | 1,067,898 | 1,195,724 | 2,263,622 | Apr 13, 2017 · 2:45 pm EDT | Form 4 |
| Ira A GreensteinDirector | 331,051 | — | 331,051 | Mar 12, 2015 · 4:24 pm EDT | Form 4 |
| Samuel BackenrothChief Financial Officer | 212,596 | — | 212,596 | Apr 13, 2017 · 12:59 pm EDT | Form 4 |
| Orin HirschmanDirector | — | 138,200 | 138,200 | Dec 6, 2017 · 3:41 pm EST | Form 4/A |
| Irach B. TaraporewalaChief Executive Officer | 22,800 | — | 22,800 | Mar 12, 2015 · 4:13 pm EDT | Form 4 |
| June Sherie AlmenoffDirector | 16,900 | — | 16,900 | Mar 12, 2015 · 4:17 pm EDT | Form 4 |
| Thomas M RiedhammerDirector | 8,000 | — | 8,000 | Mar 12, 2015 · 4:20 pm EDT | Form 4 |
| Avner IngermanChief Clinical Officer | 1,500 | — | 1,500 | Mar 2, 2015 · 10:58 am EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.